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Multiple Sclerosis (MS) is an autoimmune disease of unknown etiology, 
characterized by a wide range of physical, cognitive, psychological, and behavioral 
symptoms. To effectively diagnose and treat MS, clinicians rely on patient reports of 
function to help identify and treat their problems (Kinsinger, Lattie, & Mohr, 2010). 
Specifically, self-reports of cognitive symptoms are a valuable source of information 
upon which clinicians depend (Van der Hiele, Spliethoff-Kamminga, Ruimschotel, 
Middelkoop, & Visser, 2012). While patient reports of cognitive functioning, including 
memory, are important, there has been substantial debate about the accuracy of such 
information. The present study investigated the association between general cognitive 
impairment, depression, anxiety, and personality function among MS patients, and 
determined how such variables related to the accuracy of MS patient reports of memory 
function. Findings indicated that increases in anxiety, depression, somatization, and 
negative impression management were all associated with a decrease in the estimation of 
memory function. Alternatively, an increase in positive impression management was 
associated with an increase in estimation of memory function. Cognitive function was not 
significantly correlated with estimation of memory function, though emerged as the only 
significant predictor of estimation of memory in the regression analysis. Findings 
highlight the presence of psychological concerns among MS patients and support the 
impact of cognitive function on the estimation of patient reported memory symptoms. To 
comprehensively, and efficaciously, treat individuals with MS, clinicians should interpret 
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Multiple Sclerosis (MS) is an autoimmune disease of unknown etiology 
characterized by a wide range of physical, cognitive, psychological, and behavioral 
symptoms. It is among the most frequent causes of disability in early to middle adulthood, 
impacting 100-130 per 100,000 people in the United States (Kurtzke & Wallin, 2000). In 
fact, Ogden (2005) noted that MS is the most common nontraumatic neurological 
disorder impacting young adults. MS onset occurs, on average, at around 30 years of age 
(Kurtzke, Page, Murphy, & Norman, 1992), with fewer than 10% of MS patients 
experiencing disease onset before puberty or after 55 years of age (Ogden, 2005). MS is 
twice as common in women relative to men (Beatty, 1996) and twice as common among 
White ethnic groups relative to Black ethnic groups (Ogden, 2005). 
To effectively diagnose and treat MS, clinicians rely on patient reports of function 
to help identify and treat their problems (Kinsinger, Lattie, & Mohr, 2010). Specifically, 
self-reports of cognitive symptoms are a valuable source of information upon which 
clinicians depend (Van der Hiele, Spliethoff-Kamminga, Ruimschotel, Middelkoop, & 
Visser, 2012). While patient reports of cognitive functioning are important, there has 
been substantial debate about the accuracy of such information.  
Multiple studies (Basso et al., 2008; Marrie, Chelune, Miller, & Cohen, 2005; 
Matotek, Saling, Gates, & Sedal, 2001; Randolph, Arnett, & Higginson, 2001) have 
found that patient reported cognitive difficulty is related to neuropsychological test 
performance, while others (Beatty & Monson, 1991; Maor, Olmer, & Mozes, 2001; 
Middleton, Denny, Lynch, & Parmenter, 2006) have not. In fact, MS patients have been 
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found to both underestimate and overestimate their cognitive performance. A careful 
review of the available literature suggests there are multiple factors that influence MS 
patients’ ability to accurately report their cognitive functioning, including level of 
cognitive impairment, depression, anxiety, and personality dysfunction. The relationship 
between each of these variables and the accuracy of cognitive symptom reporting has 
been investigated, though the literature on anxiety and personality is notably sparse. 
While it is generally understood how each of these variables individually influences 
cognitive symptom reporting, there have been no comprehensive studies examining the 
manner in which cognitive impairment, depression, anxiety, and personality dysfunction 
collectively relate to the accuracy of cognitive symptom reporting.  
Statement of the Problem 
As noted above, there is limited research investigating the manner in which 
anxiety and personality are related to the accuracy of MS patient cognitive symptom 
reporting. Given that anxiety and personality dysfunction are common among MS 
patients (Rintell, 2012; Stathopoulou, Christopoulos, Soubasi, & Gourzis, 2010), it is 
necessary to understand how such variables are related to the accuracy of cognitive 
symptom reporting. Additionally, the available evidence suggests that cognitive 
impairment, depression, anxiety, and personality function influence each other (Bruce & 
Lynch, 2011). However, extant research is limited in that it has not fully examined the 
manner in which cognitive impairment, depression, anxiety, and personality function 
collectively influence the accuracy of symptom reporting. While the individual impact of 
the aforementioned factors has been examined to varying degrees, the relationship 
between them and their collective influence on cognitive symptom reporting remains a 
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relative mystery, potentially leading to misdiagnosis or improper treatment of individuals 
with MS. Additionally, there have been no investigations of the manner in which cultural 
and demographic factors influence MS patient reports of cognitive symptoms. 
Purpose of the Present Study 
The purpose of the present study is to investigate the association between 
cognitive impairment, depression, anxiety, personality function, and cultural factors 
among MS patients, and determine how such variables relate to the accuracy of MS 
patient reports of memory function. Memory function is the primary cognitive domain of 
interest due to the fact that memory difficulties are common and often clinically reported 
as a domain of cognitive difficulty by MS patients (Rao, Grafman, & Dijkerman, 1993). 
The present study will thus investigate the role of each of the aforementioned variables, 
and explore their relation to the accuracy of cognitive symptom reporting.  
Research Questions 
The present study will investigate the following research questions: 
1. How do cognitive impairment, depression, anxiety, and personality function 
individually and collectively relate to the accuracy of MS patient reported 
memory function? 
2. Does the accuracy of patient reported memory function differ by race/ethnicity, 
sex, educational level and age?  
Clinical Implications 
From both an assessment and treatment perspective, it is important for clinicians 
to be aware of how factors such as cognitive impairment, depression, anxiety, and 
personality may influence the accuracy of patient reports of cognitive function. 
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Determining what factors influence cognitive symptom reporting will inform clinical 
practice by helping clinicians diagnosing MS determine the appropriate battery of 
neuropsychological tests to administer. For example, a patient who presents with 
depression and anxiety may be more likely to report a high number of cognitive 
symptoms, relative to a patient who is free of psychological difficulty. In this case, the 
high number of reported cognitive symptoms may lead the clinician to more thoroughly 
assess the patient’s psychiatric functioning. As previously noted, cognitive and 
psychological impairment may result in patients under- or over-reporting their cognitive 
symptoms, and knowing such information may lead to more appropriately tailored 
assessments. Clinicians may want to include or exclude various psychological or 
cognitive assessments in their exam, depending on the degree to which depression, 
anxiety, personality, and cognitive function possibly contribute to patients’ reports of 
cognitive symptoms. 
Perhaps more significantly, the knowledge produced by the present research may 
impact the focus of treatment for MS patients. Treatment professionals frequently rely on 
patient self-report for evaluation and treatment planning. If a patient’s cognitive 
complaints are largely influenced by mood, the appropriate treatment may be 
psychotherapy rather than cognitive rehabilitation. For example, a patient may report 
multiple cognitive difficulties, though may not demonstrate any when formally assessed. 
If the patient were not cognitively impaired, it would be useful for the clinician to know 
what factors were contributing to the patient’s report of symptoms so that the appropriate 
treatment may be recommended. Alternatively, if a patient with MS reports cognitive 
deficits and is free of psychological difficulty, clinicians may be more confident in 
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directing treatment towards alleviating the cognitive difficulties rather than 
recommending psychotherapy or psychopharmacologic intervention. It is thus important 
for individuals involved in MS patient treatment to understand what factors influence 



























While cases of MS have potentially been observed for hundreds of years, the 
scientific community has, until recently, failed to fully understand the multidimensional 
nature of the disease. For instance, it was only within the last 30-40 years that cognitive 
dysfunction was recognized as a major component of MS, and even more recently that 
the impact of psychological variables on MS was even considered. Given that MS 
impacts most areas of afflicted individuals’ lives, it is important that researchers and 
practitioners assess and treat patients in a comprehensive and sensitive manner.  
MS is a complex disease of unknown etiology. While the cause remains unknown, 
a wide variety of epidemiologic studies have identified various risk factors for developing 
the disease. Individuals who live further from the equator, smoke cigarettes, are deficient 
in vitamin D, are between the ages of 30-50 years old, are female, are Caucasian, or have 
a relative with MS are at increased risk of developing MS.  
Currently, there is no single assessment used to determine the presence of MS. 
Instead, MS is defined by the presence of neurological symptoms distributed in time and 
space within the CNS, without a better explanation (Miller, 2006). While multiple 
diagnostic criteria have been used to diagnose MS (McDonald et al., 2001; Polman, 
Reingold, Banwell et al., 2011; Polman, Reingold, Edan et al., 2005; Poser, Paty, & 
Scheinberg, 1983), the most recent criteria for the diagnosis of MS are the revised 2010 
McDonald criteria (Polman et al., 2011). These criteria state that MS can be diagnosed 
when there is evidence of two separate attacks that involve multiple, discrete locations 
within the CNS. An attack is defined as any neurological disturbance lasting more than 
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24 hours and may include symptoms reported by patients themselves or discovered on 
clinical exam. While MS can be diagnosed on patient report alone, in most circumstances 
an MRI of the brain or cerebral spinal fluid testing is also recommended, which allows 
clinicians to rule out alternative explanations for the neurologic symptoms (e.g. stroke, 
brain tumor, infection). In fact, more than 95% of people with MS demonstrate CNS 
abnormalities on MRI findings (Sahraian & Radue, 2008). 
MS is characterized by the formation of sclerotic plaques that develop as a result 
of tissue damage in the CNS. Such plaques tend to form in the white matter areas of the 
CNS, though the lesions can be found in any part of the CNS (Kidd et al., 1999; 
Noseworthy, Lucchinetti, Rodriguez, & Weinshenker, 2000). In many areas of the CNS, 
myelin wraps around the axons of neurons and facilitates more rapid nerve conduction. 
MS interferes with this process by damaging the myelin, which initially slows nerve 
conduction. However, if the demyelination is more severe or there is axonal damage, 
impulse conduction maybe lost completely, leaving afflicted individuals with more 
permanent loss of neurological function (Noseworthy et al., 2000).  
Most commonly, lesions are found in the periventricular areas, subcortical white 
matter of cerebral hemispheres, corpus callosum, and the spinal and optic nerves (Ogden, 
2005), though they can occur in any area of the central nervous system where there is 
myelin. In addition to variation in location, lesions may also vary by type. They may be 
inflammatory and acute with improvement occurring over a period of days to weeks, or 
may remain permanently without resolution of symptoms (Ogden, 2005). Both the 
location and type of lesions can vary greatly between individuals and even within the 
same individual, which can subsequently produce a wide variety of symptoms. 
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Although Charcot described memory and concept formation difficulty in his 
initial lectures (Charcot, 1877), the cognitive manifestations of MS were underestimated 
and rarely discussed in the literature for multiple decades (Ari, Benedict, LaRocca, & 
Caruso, 2013). In fact, MS was previously thought to be primarily a gait and sphincter 
(i.e., bowel and bladder) disorder (Scheinberg & Smith, 1987). Fischer (2001) suggested 
that the medical community has historically underestimated the cognitive dysfunction 
associated with MS because cognitive deficits were difficult to detect, and it was 
prevailing knowledge, albeit inaccurate, that cognitive dysfunction rarely occurred in MS 
and if it did, it was only in severe cases.  
With advances in technology, assessment procedures, and the scientific 
understanding of the disease, it is now known that approximately 40-60% of individuals 
with MS experience cognitive dysfunction (Demaree, Deluca, Gaudino, & Diamond, 
1999; van der Hiele et al., 2012). Although cognitive dysfunction is relatively common, 
cognitive difficulties are rarely reported among the presenting symptoms of MS (Patty, 
2000), presumably due to the overwhelming presence of physical symptoms. 
Additionally, cognitive symptoms are easily overlooked in routine neurological exams 
(Rao, 1995), as brief screening measures tend to lack the sensitivity to detect subtle 
cognitive changes.  
Specific cognitive symptoms experienced largely depend on the location of an 
individual's lesions. However, the most common cognitive problems associated with MS 
involve speed of information processing, memory, and executive functioning (Ari et al., 
2013; Bobholz & Gremley, 2011; Van der Hiele et al., 2012).   
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As noted above, information processing difficulties are thought to be common 
among MS patients (Bobholz & Gremley, 2011). MS patients have consistently been 
found to perform more poorly than controls on tasks requiring rapid information 
processing (Deluca, Berbieri-Berger, & Johnson, 1994; Rao, Leo, Bernardin, & 
Unverzagt, 1991). However, studies have shown that information processing difficulty in 
MS is primarily related to speed, not necessarily comprehension. When patients were 
given adequate time to process test stimuli, they performed similarly to controls on 
memory tasks (Arnett, 2004; DeLuca, Chelune, Tulsky, Lengenfelder, & Chiaravalloti, 
2004; Demaree et al., 1999; Denney, Lynch, & Parmenter, 2008). 
Memory decline is also among the most common MS-related cognitive 
difficulties, impacting 40 to 60% of MS patients (Rao et al., 1993). The most notable 
difficulty tends to be with explicit memory tasks, while autobiographical and implicit 
memory are generally left intact. Working memory deficits have also been observed in 
MS patients, though these are thought to be related to processing speed difficulties (Rao 
et al., 1993).  
Lastly, individuals with MS tend to have more difficulty than those without MS 
on tests of executive functioning, showing more difficulty with decision making and 
problem solving (Birnboim & Miller, 2004; Brassington & Marsh, 1998). Related to 
executive functioning, MS patients have also been found to have difficulty with semantic 
and phonemic fluency (Henry & Beatty, 2004). Deficits in executive function can impact 
one’s ability to plan for and manage the demands of daily life, and have also been 
associated with self-awareness and self-monitoring (Smith, 2007).  
Cognitive Symptom Reporting 
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There are many methods used to obtain information regarding cognitive 
symptoms, one of which is patient self-report. Self-reports of cognitive symptoms are a 
valuable source of information that clinicians use to help identify and treat their patients’ 
cognitive problems (Kinsinger, Lattie, & Mohr, 2010). Understanding what factors 
contribute to the accuracy of MS patient reports of cognitive functioning will allow 
clinicians to more effectively assess and treat individuals with MS. As noted previously, 
there is a high degree of inconsistent findings regarding the accuracy of MS patient 
reports of cognitive impairment. The available literature indicates that cognitive 
impairment itself, as well as depression, anxiety, and personality function may account 
for such variability in findings, as each may relate to the manner in which MS patients 
report cognitive function. 
Additionally, research suggests that cultural and demographic variables such as 
sex, race, or ethnic background may influence the manner in which individuals express 
psychological and cognitive symptoms. For example, relative to the U.S. where an 
emphasis is placed on the open expression of emotion, many other cultures value non-
confrontation and social harmony, which may result in individuals being less likely to 
report concerns to health care providers (Kirmayer, 2001). In fact, cultural expression of 
depression and anxiety, and subsequently cognitive symptoms, likely varies widely even 
within the U.S. given the unique cultural variability of the population. However, there 
have been no investigations of the manner in which cultural and demographic factors 
influence MS patient reports of cognitive symptoms. The available literature 
investigating the relationship between cognitive impairment, depression, anxiety, 
personality function, and cognitive symptom reporting will be reviewed below.  
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Cognitive impairment. The available literature investigating the relationship 
between cognitive dysfunction and symptom reporting is relatively sparse. Multiple 
studies have found that MS patients with cognitive impairment are, in fact, able to 
accurately report the nature of their cognitive difficulties. However, as will be 
demonstrated below, the severity of cognitive impairment appears to significantly 
influence how patients perceive their own cognitive function.  
Multiple studies have consistently found that cognitively impaired patients with 
MS can accurately report the nature of their difficulties. In fact, some studies have found 
that MS patients’ reports of cognitive difficulty were more accurate than informant 
reports of MS patient cognitive difficulty (Randolph, Arnett, & Higginson, 2001). Similar 
studies (Matotek, Saling, Gates, & Sedal, 2001; Smith & Arnett, 2010) investigating the 
relationship between MS patient complaints of cognitive difficulty, specifically memory 
and executive function difficulty, and actual cognitive performance also found that MS 
patients are generally able to accurately report their level of cognitive impairment. 
Adding to the robustness of these findings is the fact that each study utilized different 
measures of cognition and patient report of cognitive difficulty, and investigated different 
domains of cognition. Notably, both Matotek et al. (2001) and Smith and Arnett (2010) 
studied participants who experienced a mild form of MS and were subsequently only 
mildly cognitively impaired. While Randolph et al. (2001) did not report participant 
disease severity or level of impairment, they do note that all patients were capable of 
being seen in an outpatient clinic and none of them were experiencing symptom 
exacerbation, facts that lead to the assumption that they were a relatively high functioning 
and unimpaired group. This is an important fact because, as will be shown below, the 
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level of cognitive impairment appears to significantly influence patients’ abilities to 
perceive and report their own cognitive difficulties.  
Determining whether MS patients can accurately report their own cognitive 
difficulties has been a hotly debated topic. Studies, such as those listed above, suggest 
that MS patients are good reporters of their own cognitive function. Others, such as 
Beatty and Monson (1991), found that MS patients failed to acknowledge their memory 
difficulties on self-report measures, suggesting that MS patients are poor reporters of 
their own impairment. While each of these studies is compelling, it seems that they do 
not tell a comprehensive story. In fact, MS patients can be both inaccurate and accurate 
reporters of their own cognitive abilities. For example, Goverover, Chiaravalloti, and 
DeLuca (2005) found that as MS patient reports of cognitive function became more 
inaccurate, so too did their level of cognitive impairment, implying that more cognitively 
impaired MS patients failed to perceive their own cognitive symptoms, a finding 
supported by the following studies.  
Carone, Benedict, Munschauer, Fishman, & Weinstock-Guttman (2005) found 
that MS patients who overestimated their cognitive function were less depressed and 
experienced a greater degree of cognitive impairment, relative to those who accurately 
perceived or underestimated their cognitive abilities. Such findings indicate that mood 
may influence patient reports of cognitive difficulty, but perhaps more significantly, a 
greater degree of cognitive impairment may be related to overestimation of cognitive 
function. Notably, accuracy of patient reports was determined by the degree that patients’ 
reports of cognitive difficulty differed from informant ratings of patient cognitive 
impairment. Unfortunately, as Randolph et al. (2001) noted, informant reports of patient 
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cognitive difficulties are not necessarily more accurate. While this is a relatively common 
way to determine patient accuracy, it is important to note that informant reports can be 
influenced by multiple factors as well and should not be considered the standard measure 
of accuracy. Preferably, MS patient reports of cognitive difficulty should be compared to 
neuropsychological test results for an indication of accuracy. 
Similarly, Marrie, Chelune, Miller, and Cohen (2005) examined the relationship 
between objectively measured and patient-reported cognitive impairment and found that 
among patients with mild or no cognitive impairment, perceptions of impairment were 
consistent with actual cognitive deficits. However, patients with more severe deficits 
tended to perceive themselves as unimpaired. Additionally, the relationship between 
memory impairment and patient reports of cognitive difficulty was modified by age, such 
that among young individuals, decreased memory ability was associated with increased 
reports of cognitive impairment, though there was no association for individuals over age 
65 years with memory ability. 
As demonstrated above, MS patients who are mildly impaired tend to accurately 
perceive and report their cognitive difficulties. However, consistent with Carone et al. 
(2005), Goverover, Chiaravalloti et al. (2005), and Marrie et al. (2005), as cognitive 
impairment becomes more severe and patients age, they tend to lack awareness and 
underestimate their cognitive difficulty. The findings also suggest that older age, 
presumably associated with greater cognitive impairment, is associated with less 
awareness of cognitive difficulty. 
The available literature investigating the relationship between patient-reported 
cognitive impairment and actual cognitive impairment is both limited and seemingly 
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conflicting. However, a closer review has revealed that MS patients’ abilities to report 
their level of cognitive difficulty are dependent on their level of cognitive impairment. A 
greater degree of cognitive impairment among MS patients is associated with 
overestimating one’s cognitive ability and reporting fewer cognitive symptoms.  
Depression. Depression is, by far, the most studied psychological aspect of MS. It 
was the first recognized psychological consequence of MS, and for many years was 
thought to be the only psychological difficulty experienced by MS patients. While 
depression affects approximately 6% of the U.S. population annually (Kessler, Chiu, 
Demler, & Walters, 2005; U.S Census Bureau, 2005), its rates in the MS population are 
much higher. It is estimated that more than 50% of patients with MS experience 
depression during the disease course (Feinstein & Feinstein, 2001; Minden, Orav, Reich, 
1987; Mohr & Cox, 2001), with annual prevalence rates around 20% (Patten, Beck, 
Williams, Barbui, & Metz, 2003). However, lifetime prevalence rates of depression are 
estimated as high as 64% when patients who do not meet diagnostic criteria for 
depression, though express depressive symptoms, are included in analyses (Feinstein & 
Feinstein, 2001; Fischer et al., 1994). While depression is common among patients with 
MS, it is unfortunately not often detected or treated (Feinstein, 2004; Siegert & 
Abernethy, 2005). In fact, McGuigan and Hutchinson (2006) examined a community-
based MS sample and found that 25% of patients reached clinically diagnosable levels of 
depression, though were unaware of their depression and had not received treatment for it.  
While it has been recognized that depression is common among MS patients, it 
has only been within the last 10-15 years that researchers began to investigate the manner 
in which depression influenced patient reports of cognitive difficulty. Overwhelmingly, 
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studies have consistently found that self-report of cognitive symptoms is more highly 
correlated with depressive symptoms than with neuropsychological test performance. In 
general, MS patients who present as more depressed tend to report a greater degree of 
symptoms associated with cognitive impairment, a trend supported by the work of 
Christodoulou et al. (2005), Goverover, Kalmar et al. (2005), Lovera et al. (2006), Maor 
et al. (2001), and Middleton et al. (2006). Each of these authors investigated the 
relationship between self-reported cognitive complaints and objective measures of 
cognitive impairment and found that depression was positively correlated with patient 
reports of cognitive impairment. Additionally, both Maor et al. (2001) and Middleton et 
al. (2006) conducted stepwise regression analyses and found that depression emerged as 
the strongest predictor of MS patient-reported cognitive impairment. Interestingly, to 
minimize the impact of depression, Christodoulou et al. (2005) and Lovera et al. (2006) 
excluded patients with moderate to severe depression. However, depression inventory 
scores were still significantly correlated with patient-reported cognitive difficulty, 
highlighting the robustness of the impact of depressive symptoms among MS patients. It 
should be noted that the strength of the association in these two studies was likely 
underestimated as a result. 
Consistent with the aforementioned studies, Kinsinger, Lattie, and Mohr (2010) 
and Julian, Merluzzi, and Mohr (2007) also found that depression was associated with an 
increase in MS patient-reported cognitive dysfunction. However, both studies 
additionally found that after receiving successful treatment for depression, MS patients 
reported fewer symptoms of cognitive dysfunction, suggesting that treating depression 
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may result in more accurate self-reporters and supporting the theory that depressive 
symptoms distort patients’ perceptions of their cognitive and functional abilities.    
As evidenced above, the available literature on cognitive symptom reporting and 
depression indicates that depression seems to have a significant impact on the manner in 
which patients perceive their own cognitive function, a finding consistent with multiple 
studies (Bruce  & Arnett, 2004; Fischer, LaRocca, Miller, Rivto, Andrews, & Paty, 1999; 
Gold, Schulz, Monch, Schulz, & Heesen, 2003). In fact, depression was consistently 
more correlated with self-reports of cognitive functioning than actual neuropsychological 
performance. Overwhelmingly, patients experiencing depression perceived their 
cognitive impairment as more severe than it actually was. Further strengthening this 
relationship is evidence from Kinsinger et al. (2010) and Julian et al. (2007), who found 
that successful treatment of depressive symptoms was associated with a more accurate 
self-report of cognitive function.  
The consistency of the above findings regarding depression is even more notable 
considering the variety of methods utilized in these studies. Studies utilized large and 
small samples, community and clinical samples, participants from locations throughout 
the United States, and participants with all forms of MS. Studies were also varied in the 
measures they used to assess cognitive symptom reporting, depressive symptoms, and 
cognitive function.  
Anxiety. In contrast to the large body of research examining depression, much 
less attention has been paid to anxiety, which Sa (2008) noted is also a cause of disability 
among patients with MS. Extant literature indicates that rates of anxiety among MS 
patients vary widely from 19 to 90% (Feinstein, O’Connor, Gray, & Feinstein, 1999; 
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Korostil & Feinstein, 2007; Minden & Schiffer, 1991; Noy et al., 1995; Pepper, Krupp, 
Friedberg, Doscher, & Coyle, 1993; Stenager, Knudsen, & Jensen, 1994). In contrast to 
18% in the U.S. population, the lifetime prevalence rate of any anxiety disorder among 
MS patients is estimated to be 36% (Korostil & Feinstein, 2007). Interestingly, Feinstein 
et al. (1999) and Noy et al. (1995) found that individuals with MS experienced higher 
rates of anxiety than depression. Such high rates of anxiety among MS patients are not 
surprising given the chronic and unpredictable nature of MS. Individuals with MS must 
deal with the progressive limitations imposed by the disease, adapt to family and social 
demands, deal with unpleasant self-injectable medications, and continually adjust their 
sense of self as they live with MS on a daily basis (Sa, 2008). Available evidence 
suggests that anxiety is common among patients with MS, though like depression, it is 
not often detected or treated (Rintell, 2012). For example, Korostil and Feinstein (2007) 
found that none of the MS patients in their study, who were experiencing clinical anxiety, 
were previously diagnosed or treated. Below is a review of the available literature 
addressing the manner in which anxiety influences the accuracy of patient reports of 
cognitive difficulty.  
Within the available literature there are three investigations of the manner in 
which anxiety influences patient self-reports of cognitive functioning. Similar to findings 
regarding depression and self-report of cognitive symptoms, the available literature 
indicates that those with higher levels of anxiety also tend to report a greater degree of 
cognitive impairment, generally incongruent with their actual cognitive performance.  
Akbar et al. (2011) and Middleton et al. (2006) examined perceptions of cognitive 
functioning relative to performance on cognitive tests among MS patients. Both authors 
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found that self-reports of cognitive difficulties were not matched by objective data 
obtained from neuropsychological testing and that anxiety was positively correlated with 
patient reports of cognitive difficulties. Additionally, Akbar et al. (2011) and Middleton 
et al. (2006) each conducted a hierarchical regression analysis and found that anxiety was 
a better predictor of patient-reported cognitive impairment than depression. Consistent 
with the findings of Akbar et al. (2011) and Middleton et al. (2006) are the findings of 
van der Hiele et al. (2012), who examined the psychological characteristics of MS 
patients who underestimated and overestimated their executive function abilities. While 
many participants were able to accurately report their cognitive difficulties, those who 
reported more executive dysfunction than was evidenced by neuropsychological testing 
were characterized by more depression, anxiety, and psychosocial stressors than those 
who were accurate or underestimated their executive function performance.  
The available literature investigating the relationship between anxiety and self-
reported cognitive function is sparse, but consistent. Despite the use of different self-
report measures of depression, anxiety, and cognitive abilities, each of these studies 
found that anxiety was positively associated with self-reported cognitive impairment. In 
fact, both Akbar et al. (2011) and Middleton et al. (2006) found that anxiety was more 
strongly associated with patient-reported cognitive impairment than depression. Similar 
to the trend in the depression literature, higher rates of anxiety are associated with higher 
levels of patient-reported cognitive impairment. It is important to note, however, that 
elevated levels of depression and anxiety do not relate to poorer cognitive performance.  
Notably, there is a significant lack of research on this topic, and more studies 
investigating the role of anxiety in cognitive symptom reporting are needed to support the 
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present trend. Historically, depression was the only psychological variable thought to 
impact MS patients. Interestingly, two of the three studies presented above suggest that 
anxiety may be a prominent feature of the disease and influence cognitive symptom 
reporting more than depression. Future studies should include a variety of anxiety 
measures, and investigate the manner in which anxiety relates to both depression and 
specific areas of cognitive difficulty.  
Personality. In addition to depression and anxiety, MS patients also experience 
personality disturbances (Stathopoulou, Christopoulos, Soubasi, & Gourzis, 2010). In a 
review of available literature, Stathopoulou et al. (2010) found that personality changes 
were relatively common in MS, affecting 20 to 40% of patients. Relative to controls, MS 
patients commonly have increased levels of neuroticism (Merkelbach, Konig, & Sittinger, 
2003; Ozura, Erdberg, & Sega, 2010) as well as increased social inappropriateness, 
disinhibition, apathy, emotional lability, and impulsivity (Bruce & Lynch, 2011). 
Alternatively, approximately 25% of MS patients present with a euphoric mood that is 
incongruent with their situation and not necessarily congruent with their disposition 
before the onset of MS (Mitsonis, Potagas, Zervas, & Sfagos, 2009).   
While many studies have documented personality changes in MS patients, very 
few have examined the manner in which personality changes impact patient reports of 
cognitive difficulty. The following three studies address the impact of personality factors 
on self-report measures of cognition. Although each uses the NEO Five Factor Inventory 
(NEO-FFI; Costa & McCrae, 1992), Carone et al. (2005) restricted their investigation to 
the agreeable and conscientiousness scales, making comparisons limited.  
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In addition to investigating the impact of anxiety, Akbar et al. (2011) investigated 
the role of personality on self-report measures of cognition and found that higher self-
reported cognitive difficulty was associated with higher neuroticism (i.e. high reactivity 
to stress; unstable) and lower conscientiousness (i.e. careful, vigilant, efficient, 
organized). Beyond the predictive value of anxiety, conscientiousness was the only other 
significant predictor of patient-reported cognitive impairment. Neuroticism and 
conscientiousness were the only personality factors that were related to self-reported 
cognitive difficulty, such that increased reported cognitive difficulty was associated with 
higher neuroticism and lower conscientiousness.  
Carone et al. (2005) separated MS patients into groups that overestimated, 
underestimated, and accurately estimated their own cognitive ability. MS patients who 
overestimated their cognitive function were more conscientious relative to those who 
were accurate or underestimated cognitive performance, while the opposite trend was 
observed for informant ratings of patient conscientiousness. Unfortunately, the authors 
limited their investigation to the agreeable and conscientiousness scales from NEO-FFI, 
making comparisons to other studies difficult.  
Bruce and Lynch (2011) recently examined the association between anxiety, 
depression, and personality disturbances in MS patients and suggested that a diagnosis of 
MS alone is not significantly associated with personality change, noting the possible 
contributory influence of other factors. They found that patients with clinically diagnosed 
anxiety or depression exhibited higher neuroticism and less conscientiousness than MS 
patients without anxiety or depression, a finding consistent with studies previously 
discussed. While these authors did not investigate cognitive symptom reporting, based on 
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previously discussed studies, it seems reasonable to conclude that higher levels of 
cognitive symptom reporting are associated with increased depression, anxiety, and likely 
increased neuroticism and decreased conscientiousness. In other words, the manner in 
which personality factors influence cognitive symptom reporting is moderated by other 
psychological variables such as depression and anxiety. Notably, Bruce and Lynch 
(2011) did not include measures of cognitive function in their analysis. As demonstrated 
previously, level of cognitive impairment seems to significantly influence the accuracy of 
MS patient reports of cognitive function.  
Together, these three studies suggest that cognitive impairment, depression, 
anxiety, and personality function interact to collectively influence cognitive symptom 
reporting. Although they each used the NEO Five Factor Inventory (NEO-FFI), a self-
report measure of personality function, comparisons between these studies must be made 
with caution. Both Akbar et al. (2011) and Carone et al. (2005) directly examined the 
relationship between cognitive symptom reporting and personality. However, Carone et 
al. (2005) limited their investigation to the agreeable and conscientiousness scales from 
NEO-FFI, while Akbar et al. (2011) examined all scales of the NEO-FFI. However, they 
were consistent in finding that a higher reported level of cognitive difficulty was 
associated with less conscientiousness, while reporting fewer cognitive difficulties (i.e., 
overestimating one’s cognitive ability) was associated with higher conscientiousness. 
Bruce and Lynch (2011) did not investigate cognitive function or cognitive symptom 
reporting, but did find that MS patients with clinically diagnosed anxiety or depression 
exhibited higher neuroticism and less conscientiousness. The available literature 
examining the relationship between personality and cognitive symptom reporting is 
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notably lacking. Future studies investigating the relationship between personality and the 
accuracy of MS patient cognitive symptom reporting should account for the influence of 
cognitive function, depression, and anxiety, as each has been shown to have an influence.  
Conclusion 
As outlined in the introduction, patient self-reports of cognitive function are an 
important source of information for clinicians and help guide the assessment and 
treatment of MS. While patient reports of cognitive functioning are important, there has 
been a substantial debate about the accuracy of such information. The present review has 
identified the manner in which cognitive impairment, depression, anxiety, and personality 
can influence the accuracy of MS patient reports of cognitive functioning.  
After reviewing the available literature investigating the relationship between 
patient-reported cognitive impairment and actual cognitive impairment, it is clear that MS 
patients with cognitive impairment can both accurately and inaccurately report their level 
of cognitive impairment, depending on their level of impairment. At a mild level of 
impairment, MS patients are able to accurately report their level of cognitive difficulty. 
However, increasing cognitive impairment appears to be associated with less awareness, 
such that cognitively-impaired patients report fewer problems than they are actually 
experiencing. In general, a greater degree of cognitive impairment among MS patients is 
associated with overestimating one’s cognitive ability and reporting fewer cognitive 
difficulties. 
 The opposite trends were observed for depressed and anxious MS patients. A 
large body of research supports the finding that depression has a significant impact on the 
manner in which patients perceive their own cognitive function, such that depressed MS 
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patients over-report the extent of their cognitive difficulties. In fact, two studies (Julian et 
al., 2007; Kinsinger et al., 2010) found that successfully treating depressed MS patients 
was associated with more accurate self-report of cognitive function. Although there is a 
significant lack of research investigating the relationship between anxiety and self-
reported cognitive function, the findings are consistent. Congruent with trends noted with 
depressed MS patients, increased anxiety is also associated with higher levels of patient-
reported cognitive impairment. Notably, the majority of studies reviewed found that 
anxiety was more predictive of cognitive symptom reporting than depression.  
 The trends noted in the personality literature were less prominent, though 
revealing nonetheless. The studies that allowed for comparison revealed that a higher 
reported level of cognitive difficulty was associated with less conscientiousness. When 
studies integrating depression, anxiety, report of cognitive function, and personality were 
examined, the trend became more prominent and revealed that MS patients who over-
reported their cognitive difficulties were characterized by higher depression, anxiety, 
neuroticism, and lower conscientiousness. Interestingly, these studies suggest that there 
are complex interactions among these variables, and the manner in which each of them 
influences cognitive symptom reporting is likely influenced by the others.  
In addition to the diagnostic and treatment implications discussed in the 
introduction, this information has ethical implications as well. To comprehensively treat 
patients in the most efficacious and ethical manner possible, clinicians have a duty to 
understand how psychological and cognitive factors interact and collectively influence 
patient reports of cognitive function. Given the consistent relationships demonstrated 
above, it is not difficult to imagine MS patients being misdiagnosed or mistreated as a 
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result of their presentation and report of symptoms, likely the result of many variables 
that may or may not be recognized. Knowing how cognitive impairment, depression, 
anxiety, and personality impact cognitive symptom reporting is thus critical for ethical 
treatment of MS patients.  
In conclusion, both cognitive and psychiatric difficulties (e.g., depression, anxiety, 
personality changes) occur frequently in patients with MS, and are attributed to both 
cerebral demyelination and the psychosocial impact of a chronic, usually progressive, 
disabling illness (Stathopoulou et al., 2010). The evidence presented above suggests that 
cognitive impairment, depression, anxiety, and personality function influence each other. 
However, extant research is limited in that it has not fully examined the manner in which 
cognitive impairment, depression, anxiety, and personality function collectively influence 
symptom reporting. While the individual impact of the aforementioned factors has been 
examined to varying degrees, the relationship between them and their collective influence 
on cognitive symptom reporting remains a relative mystery, and is a notable area of 
















Participants in the present study were retrospectively identified from the Center 
for Neuropsychological Services at the Aurora St. Luke’s Medical Center in Milwaukee, 
WI. All participants were referred for neuropsychological evaluation to assist with MS 
diagnosis or track MS progression.  
Participant eligibility. Participants were eligible for inclusion if they meet the 
following criteria: (1) the patient had a diagnosis of MS; (2) the patient was evaluated at 
the Center for Neuropsychological Services at the Aurora St. Luke’s Medical Center; (3) 
the patient produced a valid personality profile based on the validity scales of the 
Personality Assessment Inventory; and (4) complete data were available for the patient. 
The patient was excluded from participation if s/he did not have complete test scores (i.e. 
missing data) or produced an invalid personality profile, as the inclusion of invalid 
personality profiles could bias the results. Only data from the patient’s initial evaluation 
was used in cases in which testing occurred more than once.  
Variables and Measures 
Patient-reported memory impairment. The Structured Inventory of Malingered 
Symptomatology (SIMS; Smith & Burger, 1997) was used to assess patient-reported 
memory impairment. The SIMS is a multi-axial, self-administered measure developed as 
a screening tool for detecting feigned or exaggerated psychiatric disturbance and 
cognitive dysfunction. It consists of five non-overlapping scales including Psychosis, 
Neurologic Impairment, Amnestic Disorders, Low Intelligence, and Affective Disorders. 
For the purposes of the present study, only data from the 15-item true/false Amnestic 
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Disorders scale was utilized, as items included in this scale specifically relate to memory 
function. Raw scores range from 0-15, with 0 indicating all false responses and 15 
indicating all true responses, and were converted to standard scores for analysis. Internal 
consistency for the Amnestic Disorders scale is satisfactory (α = .83) (Windows & Smith, 
2005). Total score test-retest reliability is adequate (r = .72) (Windows & Smith, 2005). 
Convergent validity is supported by high correlations between SIMS scores and similar 
measures such as the MMPI F Scale (r = .84) and F-K index (r = .81) (Schretlen & 
Arkowitz, 1990).  
 Personality. The Personality Assessment Inventory (PAI; Morey, 1991) is an 
assessment of personality consisting of 344 items and 22 non-overlapping scales. The 
four validity scales include the Inconsistency and Infrequency scales designed to detect 
deviations in responding, as well as the Negative and Positive Impression Management 
scales designed to assess patients’ attempts to present themselves in an unfavorable or 
favorable manner. The clinical scales include the Somatic, Anxiety, Anxiety-Related 
Problems, Depression, Mania, Paranoia, Schizophrenia, Borderline Features, Antisocial 
Features, Alcohol Problems, and Drug Problems. Additionally, there are 5 treatment 
consideration scales and two interpersonal scales. For the purposes of the present study, 
analysis was limited to the Somatic, Negative Impression Management (NIM), and 
Positive Impression Management (PIM) scales, as these are the only scales hypothesized 
to relate to the accuracy of cognitive symptom reporting.  
The median internal consistency across full sales is satisfactory (α = .81). Test-
retest reliability is .83. The Somatic scale is correlated with the Wiggins Health Concerns 
(r = .80) and Organic Problems (r = .82) content scales, and the Wahler Inventory (r 
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= .72), indicating satisfactory convergent validity (Morey, 1996). The NIM is 
significantly correlated with the MMPI F scale (r = .54) and the PIM is associated with 
Marlow-Crowne Social Desirability scale (r = .56) and the MMPI K (r = .47) and L (r 
= .41) scales (Morey, 1991), all indicating acceptable levels of convergent validity. 
Depression. The Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 
1996) is a 21-item, multiple-choice, self-report measure of depression. Each of the 21 
items includes a list of four statements arranged in increasing severity about a particular 
symptom of depression (i.e., I do not feel sad, I feel sad much of the time, I am sad all the 
time, I am so sad or unhappy that I can’t stand it). Scores of 0-13 indicate minimal 
depression, 14-19 mild depression, 20-28 moderate depression, and 29-63 severe 
depression. Internal consistency values have ranged from .84-.93 (Al-Musawi, 2001; 
Beck, Steer, Ball, & Ranier, 1996; Schulenberg & Yutrzenka, 2001). Test-retest 
reliability ranges from .74 to .96 (Al-Musawi, 2001, Beck et al., 1996). The BDI-II is 
highly correlated with other measures of depression including the SCID-I (r = .83), CES-
D (r = .69), and the Reynolds Adolescent Depression Scale (r = .84), indicating strong 
convergent validity. Divergent validity is supported by findings that the BDI-II is 
negatively correlated (r = -.10 to -.46) with measures of happiness, ego strength, and 
boldness (Al-Musawi, 2001). 
  Anxiety. The Beck Anxiety Inventory (BAI; Beck & Steer, 1993) is 21-item, 
multiple-choice, self-report measure of anxiety. Each of the 21 items is composed of a 
symptom of anxiety (i.e. nervous, shaky, heart pounding) and four possible patient 
endorsements (not at all, mildly, moderately, severely).  Scores of 0-7 indicate minimal 
anxiety, 8-15 mild anxiety, 16-25 moderate anxiety, and 26-63 severe anxiety. Internal 
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consistency is high (α = .94), and test-retest reliability is acceptable (r = .67) (Fydrich, 
Dowdall, & Chambless, 1992). Convergent validity is acceptable with the Hamilton 
Anxiety Rating Scale, (r = .51) and the State-Trait Anxiety Inventory (r = .58 for the 
State and r = .47 for the Trait subscales (Leyfer, Ruberg, & Woodruff-Borden, 2006).  
Memory function index score. Data from the following measures was combined 
into an index of overall memory function. Combining individual assessment scores 
according to Rohling’s Interpretive Method (RIM; Miller & Rohling, 2001) is common 
practice and creates an easily interpreted score produced from a flexible battery approach 
to neuropsychological testing. The memory function index score was used in conjunction 
with the SIMS score to create a difference score representing the accuracy of patient-
reported memory function.   
 Wechsler Memory Scale – IV (WMS–IV). The WMS-IV (Wechsler, 2009) is a 
standardized assessment of memory consisting of 7 subtests. For the purposes of the 
present study, only the Logical Memory (LM) and Visual Reproduction (VR) subtests 
were utilized, as they were the only 2 subtests administered to patients. The LM subtest is 
a measure of immediate, delayed, and recognition auditory memory, while the VR subtest 
is a measure of immediate, delayed, and recognition visual memory (The Psychological 
Corporation, 2002). LM scores include LM I Immediate Recall Total, LM II Delayed 
Recall Total, and LM II Recognition Total. Each raw score is converted to a scaled score 
(M = 10, SD = 3). VR scores include VR I Immediate Recall Total, VR II Delayed Recall 
Total, and VR II Recognition Total. Again, each raw score is converted into a scaled 
score (M = 10, SD = 3). Internal consistency was high for VR II (α = .97) and VR I (α = 
.93) (Wechsler, 2009). Additionally, internal consistency was adequate for LM II (α = 
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.85) and LM I (α = .82) (Wechsler, 2009). The VR and LM subtests were only 
moderately correlated, indicating reasonable discriminant validity. Concurrent validity is 
supported by strong correlations between the WMS-IV auditory memory index and the 
California Verbal Learning Test-II (r = .63) (Wechsler, 2009). 
 Hopkins Verbal Learning Test–Revised (HVLT–R). The HVLT–R (Brandt & 
Benedict, 2001) is a brief word list designed to assess memory. Patients’ immediate, 
delayed, and recognition memory of words are assessed. Scores include recall total, 
delayed recall, and recognition/discrimination. Raw scores are converted into T-scores 
(M = 50, SD = 10). Test-retest reliability is .74 for recall total, .66 for delayed recall, 
and .40 for recognition (Benedict & Zgalijardic, 1998). Shapiro, Benedict, Schretlen, and 
Brandt (1999) note a correlation of .77 between the HVLT–R and Wechsler Memory 
Scale – Revised (WMS-R; Wechsler, 1987) LM delayed recall, and a correlation of .69 
between HVLT-R and WMS-R VR delayed recall, indicating adequate convergent 
validity. Recognition/discrimination scores were excluded from analysis due to 
inconsistent inclusion in patient records.  
 Brief Visuospatial Memory Test–Revised (BVMT–R). The BVMT–R (Benedict, 
1997) is a brief test of visual memory. Although initially intended to be included, the 
BVMT-R was not used in the present study because it was only administered to a 
minority study participants. Including BVMT–R data would have severely limited the 
number of participants included in the analyses. 
 Overall cognitive function index. The measures below represent a wide range of 
cognitive domains and will be combined into an index of overall cognitive function. The 
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cognitive function index score produced by the following tests was used to predict 
variance in the criterion variable.  
 Wisconsin Card Sorting Test (WCST). The WCST (Berg, 1948) is a measure of 
cognitive set shifting, or the ability to maintain flexibility as situational demands change. 
It is thought to be a general test of executive function and abstract reasoning (Heaton, 
Chelune, Talley, Kay, & Curtiss, 1993), and requires patients to match a stimulus card to 
one of four key cards based on a changing set of criteria. Scores are calculated for 
number of categories completed, perseverative responses, failure to maintain set, and 
total number of errors. Heaton et al. (1993) found that generalizability coefficients ranged 
from .39 to .72, indicating acceptable internal consistency. Additionally, Heaton et al. 
(1993) also found that patients with MS consistently performed worse than healthy 
controls on the WCST.  
 Boston Naming Test (BNT). The BNT (Kaplan, Goodglass, & Weintraub, 1983) 
is a measure of confrontational naming and consists of 60 pictures that patients are asked 
to name. The BNT is sensitive to individuals with frontal or temporal lobe impairment 
(Mitchell & Crow, 2005), though picture-naming difficulty is often used as an indirect 
measure of more global cognitive impairment. Internal consistency is .96 (Huff, Collins, 
Corkin, & Rosen, 1986) and test-retest reliability is .94 (Sawrie, Chelune, Naugle, & 
Luders, 1996). Convergent validity is supported by correlations between the BNT and the 
Gates-McGinite Reading Vocabulary Test ranging from .74 to .87 (Hawkins et al., 1993). 
The BNT is poorly correlated with the Facial Recognition Test (r = .27; Benton & Van 
Allen, 1968), evidence of strong divergent validity. 
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 Judgment of Line Orientation (JLO). The JLO (Benton, Hannay, & Varney, 
1975) is a measure of visuo-spatial processing. It consists of 30 items and tests patients’ 
abilities to estimate angular relationships between line segments. Test-retest reliability 
is .90 (Benton, Sivan, Hamsher, Varney, & Spreen, 1994).  
 Controlled Oral Word Association Test (COWAT). The COWAT (Benton, 
Hamsher, & Sivan, 1994) assesses verbal fluency. It consists of three word-naming trials 
in which the patient is told a letter (i.e. c, f, l) and asked to name as many words as s/he 
can think of that begin with that letter within a 60-second time period. Divergent validity 
is evidenced by a moderate correlation (r = .56) between the COWAT and Multilingual 
Aphasia Examination (MAE) Visual Naming (Benton et al., 1994). Benton et al. (1994) 
stated that the moderate correlation was likely the result of the similar word retrieval 
demands of each test. Additionally, a weak correlation (r = .34) between the COWAT 
and Sentence Repetition further supports strong divergent validity (Benton et al., 1994). 
 Wide Range Achievement Test: Fourth Edition (WRAT–4). The WRAT–4 
(Wilkinson & Robertson, 2006) is a measure of academic function including word 
reading, sentence comprehension, spelling, and math computation. Although initially 
intended to be included, the WRAT-4 was not used in the present study because it was 
only administered to a minority study participants. Including WRAT-4 data would have 
severely limited the number of participants included in the analyses. 
 Trail Making Test (TMT). The TMT (Partington & Leiter, 1949) measures 
scanning and visuo-motor tracking, divided attention, and cognitive flexibility (Reitan & 
Wolfson, 1993). Although initially intended to be included, the TMT was not used in the 
present study because it was only administered to a minority study participants. Including 
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TMT data would have severely limited the number of participants included in the 
analyses. 
 Demographic variables. Data was collected regarding patients’ age, age at 
diagnosis, sex, race, marital status, duration of MS, and level of education.  
Procedure 
 Approval for the present study was obtained from Marquette University’s IRB 
and Aurora St. Luke’s Medical Center RSPP/IRB. All participants completed a 
neuropsychological evaluation consisting of a clinical interview and the administration of 
a standard battery of neuropsychological tests. Order of test administration was not 
controlled, though tests were administered according to standardized test administration 
instructions, which are described in their respective administration manuals. Following 
test administration, individual tests were scored according to standardized procedures 
outlined in their respective manuals.  
Data Analysis  
When necessary, raw scores from the neuropsychological test data were 
transformed into z-scores, allowing for the computation of two index scores from scores 
on different original scales. The memory index score was composed of the Wechsler 
Memory Scale and the Hopkins Verbal Learning Test–Revised. The cognitive ability 
index score consisted of the Controlled Oral Word Association Test, Judgment of Line 
Orientation, Boston Naming Test, and the Wisconsin Card Sorting Test. Both indices 
were generated according to the steps of Rohling’s Interpretive Method (RIM; Miller & 
Rohling, 2001). RIM was designed to allow for a more easily understood interpretation of 
neuropsychological assessment data generated from a flexible battery approach to 
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neuropsychological testing. Generally, it involves assigning test scores to a specific 
conceptual domain, converting to a standardized metric, and computing an overall 
domain score. The cognitive ability index score was used as a predictor variable and did 
not include memory assessment data. The BAI, BDI, and personality scores remained in 
their original scale of measurement.  
 The memory index score was used in conjunction with the SIMS data to generate 
a difference score, representing the accuracy of patient-reported memory function and 
acting as the primary criterion variable in the present study. The difference score was 
calculated by transforming the SIMS raw score and memory index raw score into 
standardized scores, and calculating the difference between them (perceived – actual 
performance). A score of zero indicated that the participant was completely accurate. Any 
deviation from zero indicated inaccuracy, and the direction (i.e., positive or negative) of 
the difference indicated whether the participant was over- or underestimating his or her 
memory function. Possible accuracy scores ranged from -4 to 4. SIMS data were reversed 
scored so that higher scores in both perceived and actual performance represented better 
functioning, and visa versa. Negative scores indicated that participants underestimated 
their performance (i.e., reported more memory problems than testing showed), while 
positive scores indicated that participants’ overestimated their memory performance (i.e., 
reported fewer memory difficulties than testing revealed). 
First, descriptive statistics were examined in order to better understand the 
characteristics of the sample. Then, bivariate correlations of the predictors and dependent 




 To address the research questions, a model was created to investigate the 
predictors in combination. The PAI, BDI, BAI, and index of cognitive function were used 
to account for variance in the accuracy score generated from the SIMS and memory 
function index. This was done with a hierarchical regression analysis with block variable 
entry. There were four total blocks, including an anxiety block with data from the BAI, a 
depression block consisting of data from the BDI, cognitive function block with data 
from the cognitive function index score, and a personality block with data from the PAI. 
Anxiety was entered first because it was predicted that it would account for the most 
variance in the estimation of memory performance. Depression scores were entered 
second to determine if they accounted for unique variance beyond the variance accounted 
for by anxiety scores. Depression and anxiety were predicted to account for the most 
variance in estimation of memory function. Cognitive function scores were entered next 
to determine if they accounted for variance beyond the variance explained by the 
depression and anxiety scores. Personality function was the most novel aspect of the 
analysis and was entered last to determine if there was any additional contribution.  
Assumptions of linearity, normality, and multicollinearity were tested. 
Histograms were used to assess normality, and linearity was assessed with plots of 
residuals verses predicted values. Non-parametric bootstrapping was utilized (1000 
sample) due to concerns regarding small sample size and multicollinearity. Bootstrapped 
regression results did not significantly differ from non-bootstrapped results, indicating 
that that there were no major violations of assumptions. Analyses were conducted under 
the assumption that all assessments were administered in a standardized manner and that 
participants answered truthfully. 
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Although initially intended, demographic variables (e.g., age, sex, race, marital status, 
handedness, marital status, age at diagnosis, education) were not included in the 
regression analysis due to small sample size and potential model instability associated 
with too many predictor variables. Including such variables would have resulted in 
approximately 13 predictor variables, well over the theoretical limit for regression 
analyses with 86 participants. However, t-tests were conducted to explore how the 
estimation of memory function might differ by sex, marital status, education, age at 
diagnosis, or MS duration. Although any significant differences may not remain in the 
presence of other predictors, the results could be suggestive of differences to be explored 
with a larger sample. Sex was categorized by males and females. Marital status was 
categorized into married and not married. There was no distinction within the not married 
group between divorced, widowed, separated or never married. Making distinctions at 
such a level would have resulted in multiple groups with too few participants. Education 
was categorized into those who had any education beyond high school and those who 
completed high school or had fewer than 12 years of education. Again, making further 
distinction would have resulted in groups with exceedingly small sample sizes. Age at 
diagnosis was categorized into those younger than 36 years and those older than 36 years. 
The age of 36 years was chosen because it was the mean age of MS diagnosis. MS 
duration was categorized into those who had MS for 10 years or fewer and those who had 
been diagnosed for more than 10 years. Ten years was chosen because there was a natural 
break in the data and group sizes were satisfactory. Race and handedness were not 









Retrospective data were collected for 119 individuals with MS. However, due to 
missing data and exclusion criteria, the final sample consisted of 86 participants. Disease 
course was unspecified for 80 participants (see Future Study section). All participants 
were diagnosed with MS and completed neuropsychological testing at Aurora St. Luke’s 
Medical Center in Milwaukee, WI from 2006 – 2014.  The sample was primarily 
composed of Caucasian females, with an average age of 47 years (See Table 1). 
Participants scored in the average range for the cognitive index, somatization, PIM, and 
NIM variables. Anxiety and depression were endorsed at the mild level (See Table 2). 













 MS Patients (n = 
86) 
Mean Age 47 (sd = 9) 
Mean Age of MS Diagnosis 36 (sd = 11) 
Mean Years of Education  14 (sd = 3) 
Sex (M/F)(n) 20/66 
Right Handed (n) 74 
Race (n)  
    Caucasian  75 
    African American 5 
    Latino 6 
Disease Course (n)  
    Relapsing remitting 2 
    Secondary progressive 3 
    Primary progressive 1 
    Progressive relapsing   
    Unspecified 80 
Marital Status (n)  
    Married 58 
    Divorced 16 
    Never Married 10 
    Widowed 1 




There were significant correlations between MS patients’ estimations of memory 
function and predictor variables, as well as between the predictor variables themselves. 
Anxiety was most strongly associated with estimation of memory function (r = -0.44, p 
< .001), followed closely by depression (r = -0.43, p < .001), NIM (r = -0.41, p < .001), 
somatization (r = -0.39, p < .001), and PIM (r = 0.27, p < .01). The correlation between 
the cognitive ability index and estimation of memory was non-significant (See Table 2).  
Additionally, significant correlations were noted between predictor variables. 
Anxiety scores were correlated with depression (r = .75, p < .001), somatization (r = .49, 
p < .001), positive impression management (r = -.58, p < .001), and negative impression 
management (r = .61, p < .001). Depression scores were correlated with somatization (r 
= .48, p < .001), positive impression management (r = -.60, p < .001), and negative 
impression management (r = .69, p < .001). Somatization scores were correlated with 
positive impression management (r = -.32, p < .01), and negative impression management 
(r = .43, p < .001). Cognitive index scores were only correlated negative impression 

























**p < .01; ***p < .001 
 Estimation Anxiety Depress. CogIndx Somatiz. PIM NIM 
Estimation 1 -0.44*** -0.43*** -0.18 -0.39*** 0.27** -0.41*** 
Anxiety  1 0.75*** -0.17 0.49*** -0.58*** 0.61*** 
Depression   1 -0.16 0.48*** -0.60*** 0.69*** 
Cog Indx    1 -0.09 -0.02 -0.32** 
Somatization      1 -0.32** 0.43*** 
PIM       1 -0.37 
NIM        1 
M 0.0002 14.3 19.1 0.0002 8.7 (61T) 13.9 (47T) 3.4 (56T) 
SD 1.1 10.9 11.8 0.6 4.7 (13T) 5.4 (12T) 3.3 (12T) 
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Predictors 
Hierarchical linear regression was utilized to investigate predictors of patient 
estimations of memory function. Anxiety scores were entered into the model first and 
accounted for 18% of the variance in estimation of patient reported memory function 
(R² = .18, F1, 84 = 19.77, p < .001). Depression scores were added in the second step, 
(R² = .20, F2, 83 = 19.39, p < .001) but did not significantly increase the explanation of 
variance  (ΔR² = .03, F1, 83 = 2.63, ns). The cognitive index scores were added next 
and resulted in additional explanation of variance (ΔR² = .07, F1, 82 = 7.67, p < .01), 
accounting for 26% of the variance  (R² = .26, F3, 82 = 10.76, p < .001). The 
personality variables were added in the final step and resulted in additional 
explanation of variance in the estimation of memory function (ΔR² = .07, F3, 79 = 2.74, 
p < .05). The fully saturated model accounted for 30% of the variance in the criterion 
variable (R² = .30, F6, 79 = 7.09 p < .001). The final regression model was significant 
only for the cognitive index variable (B = -.57, t = -3.36, p = .001, 95% CI [-.932, -
.234]). Anxiety, depression, somatization, positive impression management, and 
negative impression management were not significant in the final regression model 
(See Table 3). Effect sizes for anxiety (B = -0.02), depression (B = -0.01), 
somatization (B = -0.04), positive impression management (B = -0.01), and negative 



















*p < .05; **p < .01; ***p < .001  
 
Predictors  B SE B β t R² Adj R² F ΔR² ΔF 
Step 1:      0.19 0.18*** 19.77 0.19*** 19.77 
Anxiety -0.04*** 0.01 -0.44 -4.45      
Step 2:     0.22 0.20*** 11.39 0.03 2.63 
Anxiety -0.03 0.02 -0.26 -1.72      
Depression -0.02 0.01 -0.24 -1.62      
Step 3:      0.28 0.26*** 10.76 0.07** 7.67 
Anxiety -0.03 0.01 -0.28 -1.98      
Depression -0.02 0.01 -0.26 -1.83      
Cognitive Index -0.46** 0.17 -0.26 -2.77      
Step 4:     0.35 0.30*** 7.09 0.07* 2.74 
Anxiety -0.02 0.02 -0.20 -1.38      
Depression -0.01 0.02 -0.11 -0.64      
Cognitive Index -0.57** 0.17 -0.33 -3.36      
Somatization -0.04 0.03 -0.19 -1.75      
PIM -0.01 0.02 -0.07 -0.59      
NIM -0.09 0.05 -0.26 -1.90      
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Demographic Variables 
 T-tests were conducted to determine how the estimation of memory function 
differed by sex, marital status, education, age at diagnosis, or MS duration. Homogeneity 
of variance was tested and taken into account. No group differences reached statistical 
significance (See Table 4). However, the effect size for martial status was notable, 
suggesting that there might be a relationship between marital status and the estimation of 
memory function in the population. Additional research should investigate martial status 
and estimation of memory with a larger sample size to further examine such relationships.  
Table IV. T-test Results Comparing Demographic Groups on Estimates of Memory    















Variable N M SD t p d Decision 
Sex        
Male 20 .09 1.31 .443 .666 .10 n/s Female 66 -.03 1.03 
Education        
≤ High School 38 .08 0.92 .615 .54 .13 n/s > High School 48 -.06 1.22 
Marital Status         
Married 58 .14 1.08 1.69 .095 .37 n/s Not Married 28 -.28 1.10 
Age at Diagnosis        
< 36 years 39 .13 1.18 .972 .334 .21 n/s ≥ 36 years 47 -.10 1.02 
MS Duration        
≤ 10 years 54 -0.12 .98 -1.37 .174 0.30 n/s > 10 years 32 .20 1.25 
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CHAPTER V: DISCUSSION 
 
 
The present study examined the relationship between cognitive impairment, 
depression, anxiety, and personality function among MS patients, and determined how 
such variables related to MS patient estimations of memory function. Memory function 
was the primary cognitive domain of interest because memory difficulties are common 
and often clinically reported as a domain of cognitive difficulty by MS patients (Rao et 
al., 1993). Overall, findings suggested that nearly all variables examined were associated 
with the estimation of MS patient-reported memory function, though cognitive function 
emerged as the only unique predictor in the regression analysis. Individual findings and 
implications are discussed below.  
The present study also sought to examine the associations between race/ethnicity, 
sex, educational level, age, and MS patient estimations of memory function. 
Unfortunately, because a significant number of participants were excluded from the study 
due to incomplete data, it was not possible to include demographics in the prediction 
equation.  However, analyses were conducted to determine if estimation of memory 
function differed based on sex, education, marital status, age, or MS duration without 
including the predictor variables.  
Prior to a discussion of study’s findings and implications, it is worth noting how 
the chosen analyses and construction of the dependent variable affect the inferences that 
can be made. The present study was unique in that it used an estimation variable created 
from MS patient perceived memory difficulty relative to actual memory performance, as 
measured with neuropsychological testing. This method is in contrast to other studies (e.g. 
Carone et al., 2005) that constructed accuracy scores using informant reports. As 
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Randolph et al. (2001) noted, informant reports are not necessarily more accurate than 
patient reports and should not be considered the standard measure of accuracy. The 
present dependent variable, estimation of patient-reported memory function, was initially 
constructed as an accuracy score. It theoretically ranged from -4 to 4, with 0 indicating 
complete accuracy between patient reports of memory function and actual memory 
function, as measured by neuropsychological testing. More negative scores were 
designed to indicate the degree to which patients underestimated their memory 
performance, while more positive scores were designed to represent the degree to which 
patients overestimated their memory performance. However, because the dependent 
variable is on a linear scale from under- to over-estimating, decreases in the dependent 
variable simply represent a decrease in the estimation of patient-reported memory 
function. The linear dependent variable does not allow for differentiation between 
decreases from overestimation to more accurate or from accurate to underestimation. 
Similarly, increases in the estimation variable simply represent an increase in the 
estimation of patient-reported memory function. Differentiation of increases from 
underestimation to accurate or from accurate to overestimation are not possible with this 
choice of methodology. As such, conclusions from the present study can only be made 
regarding patient estimations of memory performance, not accuracy.   
Additionally, the present study is unique in that it used a memory index composed 
of multiple memory tests, rather than a memory screening test, as has been done 
previously. Utilizing a memory index score ensures that the present study is actually 
measuring the construct of memory. It should also be noted that the cognitive function 
index was composed of tests that measure language abilities, visuospatial skills, and 
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executive functions. As such, implications drawn from the findings regarding the 
cognitive function index reflect these specific cognitive domains, rather than a global 
cognitive domain represented by all areas of cognitive function.  
Participants 
 Participants in the present study are representative of the general MS population. 
Most participants were Caucasian females who were, on average, approximately 47 years 
old. Although diagnosed at about 36 years of age, many participants reported 
experiencing symptoms well before actual diagnosis. However, data were not collected 
regarding this discrepancy. The majority of participants were right handed and married. 
Participants averaged 14 years of education. The sample’s similarity to the general MS 
population supports the external validity of the present study. Participants scored in the 
average range for the cognitive index, somatization, PIM, and NIM variables. Anxiety 
and depression were endorsed at the mild level. See Table 2. Although the present sample 
was relatively benign in presentation, MS can be an episodic and progressive disease. As 
such, participants may present with mild anxiety or intact cognitive function at one point, 
though dramatically decline in function at a later time.  
Bivariate Correlations 
Depression. The present study found that depression was related to the estimation 
of patient-reported memory function, such that increased depression was associated with 
a decrease in patient-estimations of memory performance. This finding is similar to 
others (Christodoulou et al., 2005; Goverover, Kalmar et al., 2005; Lovera et al., 2006; 
Maor et al., 2001; Middleton et al., 2006) who found that depression was positively 
correlated with patient reports of cognitive impairment (i.e., decreased estimation of 
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function). However, rather than examining general complaints of cognitive impairment as 
previous studies have done, the present study is unique in that it utilized a dependent 
variable representing the difference between neuropsychological test scores and 
perceived memory function. Constructing the dependent variable in such a manner would 
have characterized individuals reporting a high number of symptoms, who also had poor 
performance, as accurately perceiving their memory function. In previous studies, 
individuals reporting a high number of symptoms were characterized simply as reporting 
a high number of symptoms. Although initially intended to represent accuracy, the 
construction of the dependent variable only allows for discussion regarding general 
estimation without differentiation between over and under estimation of function. 
Nonetheless, the consistency of the findings is notable and provides additional support 
regarding the robust association between increased depression and distorted perceptions 
of memory function.  
Overall, the present study indicates that depression is significantly related to the 
manner in which patients perceive their own cognitive function when other predictors are 
excluded from the model, a finding consistent with multiple studies (Bruce  & Arnett, 
2004; Fischer, LaRocca, Miller, Rivto, Andrews, & Paty, 1999; Gold, Schulz, Monch, 
Schulz, & Heesen, 2003). In fact, in previous studies depression was consistently more 
correlated with self-reports of cognitive functioning than actual neuropsychological 
performance, a finding consistent with the present study. The strength of the association 
between depressive symptoms and cognitive symptom reporting is further highlighted by 
Kinsinger et al. (2010) and Julian et al. (2007). Both authors found that after receiving 
successful treatment for depression, MS patients reported fewer symptoms of cognitive 
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dysfunction, suggesting that treating depression may result in more accurate self-reports, 
and supporting the theory that depressive symptoms may be associated with distorted 
perceptions of cognitive and functional abilities. While the present study does not address 
such findings, the association between depression and cognitive symptom reporting is 
nonetheless supported. Overwhelmingly, greater levels of depression among MS patients 
were associated with a decrease in estimations of memory function, absent other 
predictors.  
Although depression is the most studied psychological aspect of MS and the 
direction of the relationship appears well established, it should be noted that other factors 
may also influence the expression of depressive symptoms and one’s subsequent 
perception of cognitive impairment. For example, Beier, Amtmann, and Ehde (2015) 
recently found that fatigue was a stronger predictor of general cognitive and executive 
function concerns than depression. The results from Beier et al. (2015) highlight the fact 
that the relationship between depression and cognitive symptom reporting in MS is, 
although well established, complicated by multiple factors likely influencing both the 
expression of depressive symptoms as well as patients’ reports of cognitive symptoms. 
Additional study is certainly needed to map the complexity of the relationship between 
depression and patient perceptions of function.  
It should be noted that the level of depression endorsed by the participants in the 
present study was in the mild range. If patients were experiencing more clinically 
significant depression, one might expect stronger correlations. Interestingly, 
Christodoulou et al. (2005) and Lovera et al. (2006) intentionally excluded patients with 
moderate to severe depression from their studies. However, their depression inventory 
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scores were still significantly correlated with patient-reported cognitive difficulty. The 
present study supports the robustness of this association, especially given the mild level 
of depression endorsed by participants.  
Anxiety. As noted earlier, relative to depression, anxiety has been far less studied 
in its relation to both MS and cognitive symptom reporting. However, multiple studies 
(i.e. Akbar et al., 2011; Middleton et al., 2006) have suggested that anxiety is likely 
related to cognitive symptom reporting in a manner similar to depression. Indeed, the 
present study supports the minimal, albeit consistent, body of research on the topic. 
Notably, the correlation identified in the present study suggests that an increase in anxiety 
is associated with a decrease in the estimation of memory function, when other predictors 
are excluded. In fact, of all variables analyzed, anxiety was most strongly related to the 
estimation of memory function. Although the relationship between anxiety and 
estimation was only slightly stronger than the relationship between depression and 
estimation, the trend is nonetheless consistent with Akbar et al. (2011) and Middleton et 
al. (2006), who found that anxiety was more strongly associated with patient-reported 
cognitive impairment than depression.  
The strength of the association between anxiety and cognitive symptom reporting 
should not necessarily be a surprise, especially when one considers the potential 
difficulties associated with managing a chronic and debilitating illness. Jones and 
Amtmann (2015) recently found that more MS-specific worry was related to more 
depressive symptoms, anxiety, fatigue, sleep disturbance, pain interference, worse social 
function, and perceived cognitive function. MS-specific worry, similar to health care 
worry, could include concerns about obtaining medication, high health care costs, being a 
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burden to family, or uncertainly regarding disease progression. The work of Jones and 
Amtmann (2015) supports the need to both identify and treat anxiety-related issues with 
MS patients, as doing so could be related to functional patient improvements.  
Similar to depression, it should be noted that participants, on average, endorsed a 
mild level of anxiety. Higher levels of anxiety could produce stronger correlations 
between anxiety and the dependent variable. The fact that such a correlation exists, 
despite the mild level of anxiety, again supports the robustness of the association.  
Personality. The available literature investigating the role of personality function 
in the accuracy of self-reported cognitive function is notably limited. The three available 
studies (i.e. Akbar et al., 2011; Bruce & Lynch, 2011; & Carone et al., 2005) suggest that 
cognitive impairment, depression, anxiety, and personality function influence cognitive 
symptom reporting. Although each study used the NEO Five Factor Inventory (NEO-FFI), 
comparisons between studies must be made with caution due to varied methods and foci. 
However, they were consistent in finding that a higher reported level of cognitive 
difficulty was associated with less conscientiousness, while reporting fewer cognitive 
difficulties was associated with higher conscientiousness.  
The present study did not utilize the NEO-FFI, making direct comparisons 
difficult. Rather the personality variables used in the present study included somatization, 
positive impression management, and negative impression management. Somatization 
could include the manifestation of vague physical symptoms in response to psychological 
distress, as well as general complaintiveness and dissatisfaction. Positive impression 
management is the degree to which one presents her-/himself in an overly positive light, 
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denying common shortcomings. Negative impression management is the degree to which 
one presents her-/himself in an overly negative light, denying common positive attributes.  
Findings from the present study indicated that there is, indeed, a relationship 
between such variables and the estimation of memory function. Both the somatization 
and NIM variables were negatively correlated with estimation, such that increases in 
somatization or NIM were associated with decreases in the estimation of memory 
function. Conceptually, NIM and somatization are similar, a fact that was further 
evidenced by the significant correlation between them. However, NIM implies a more 
deliberate effort to present oneself in a negative light while somatization is, by definition, 
not intentional. Nonetheless, an increase in either variable is likely to manifest similarly 
with an increased complaints and denial of positive attributes, and may further distort 
one’s perception of function. There were also significant positive correlations between 
somatization, NIM, depression, and anxiety. While the correlations do not allow for 
statements about causation, the significance certainly highlights the role of psychological 
variables in the expression of personality, and visa versa. For example, there may be a 
compounding effect regarding one’s perception of function for individuals suffering from 
a somatization disorder who are also experiencing severe symptoms of depression. 
Alternatively, it is theoretically possible that an individual who tends to present her-
/himself negatively may have more accurate perceptions of her/his function in the 
absence of mood disturbances or anxiety. 
While separating such aspects of the psyche may be difficult, clinicians should consider 
that the implications for treatment are quite different.  
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Alternatively, PIM was significantly positively correlated with the estimation 
memory function in the bivariate correlation. An increase in PIM, or one’s effort to 
present her-/himself in a favorable light, was associated with an increase in the estimation 
of one’s memory function.  Similar to depression and anxiety, it should be noted that 
participants were, on average, within normal ranges on the PAI scales utilized. 
The finding that PIM was positively correlated with estimation is not surprising, 
though it is unique, as other studies have not examined such constructs. It represents one 
of the few examinations of a variable that directly relates to one’s attempt to present her-
/himself favorably, rather than solely focusing on more negative (i.e. pathological) 
variables such as depression or anxiety. While one’s attempt to present favorably can 
certainly be characterized as pathological (e.g., narcissism), the present study suggests 
there may be more positive aspects of personality that contribute to one’s perception and 
estimation of cognitive difficulty. For example, Schmitt, Goverover, DeLuca, and 
Chiaravalloti (2014) recently found that self-efficacy, or the belief of an individual in 
her/his ability to effectively cope with challenging situations, is a primary factor in 
facilitating psychological adjustment to MS. They found that MS patients who reported 
higher levels of self-efficacy also reported better quality of life, fewer depressive 
symptoms, and had better physical functioning. Notably, the information provided in 
Schmitt et al.’s study regarding quality of life and self-efficacy was self-reported, with no 
informant reports or other measures for validation. As such, the results could be 
influenced by unaccounted-for variables. Despite this limitation, the study suggests that 
there are variables that may offset the potential effects of more pathological variables 
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such as anxiety, depression, or even maladaptive personality styles in coping with a 
diagnosis of MS.  
Cognitive function. It was expected that cognitive function would be 
significantly associated with the estimation of MS patients self-reported memory function. 
In fact, numerous previous studies (i.e. Carone et al., 2005; Goverover, Chiaravalloti et 
al., 2005; Marrie et al., 2005) suggested that as cognitive impairment becomes more 
severe, patients also tend to lack awareness and underestimate their own cognitive 
difficulty (i.e. overestimate their cognitive function). However, the analysis excluding 
other predictors, did not find such a correlation. Cognitive function, as measured by the 
cognitive index, was not significantly correlated with the estimation of memory function. 
The lack of significant correlation could be due to the relatively mild level of cognitive 
impairment demonstrated by the sample. Most participants were functioning within the 
average range, and a higher level of impairment may have resulted in stronger 
correlations. Indeed, Marrie et al. (2005) had a larger and more cognitively impaired 
sample, with 56% of participants scoring below the 5th percentile, and found that the 
relationship was curvilinear. Extant research suggests that the relationship between 
cognitive impairment and patient reported function is dependent on the level of cognitive 
impairment. That is, mildly impaired individuals are often aware of their deficits, while 
severely cognitively impaired individuals tend to claim that they are free of deficits. Such 
a relationship would not be exhibited in a linear regression analysis, though could be 
examined using scatterplots and curvilinear regression. Unfortunately, the examination of 
both yielded non-significant results. While the lack of a curvilinear relationship may 
appear to contradict previous findings, such assertions should be made with caution. Both 
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a small sample size and limited sample variability likely prohibited the observation of the 
relationship. Nearly all participants in the present study scored within one standard 
deviation of the mean, with none scoring in the lower 5th percentile. As such, conclusions 
regarding this finding should be made with caution.  
Cognitive function was, however, significantly negatively correlated with NIM, 
suggesting that as cognitive function increases, one’s tendency to present her-/himself 
negatively decreases. This may be due to increased confidence or self-efficacy that may 
accompany more intact cognitive capacities and possible accomplishments. However, 
such suggestions are purely speculative at this point, as other inquiries into the topic are 
non-existent.  
Overall, the estimation of memory function was significantly correlated with 
nearly all predictor variables. Anxiety scores were most strongly correlated with the 
estimation of memory function, followed closely by depression scores. Psychological and 
personality factors were individually more strongly correlated with estimation than 
cognitive function. In fact, the correlation between cognitive function and estimation was 
non-significant when other predictors were excluded. With the exception of the cognitive 
function scores, all correlational findings support previous research and highlight the 
robust associations between psychological variables, personality variables, and MS 
patients’ perceptions and subsequent estimations of memory function.  
Prediction Model  
A linear regression model was built to explore the independent and collective 
contributions of anxiety, depression, cognitive function, and personality to the estimation 
of memory function. Each step of the hierarchical analysis revealed that the predictors 
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accounted for significant variance in MS patients’ estimations of memory function. 
Anxiety, when entered alone, accounted for 18% of the variance in estimation scores. 
There was no effect for depression scores beyond that of anxiety scores, though the 
overall model with both variables accounted for 20% of the variance in estimation. The 
fact that depression scores did not contribute beyond the variance explained by anxiety 
scores is a relatively novel finding. Most research regarding MS patients and self-report 
of cognitive function has focused on depression, and only recently have others (Akbar et 
al., 2011; Middleton et al., 2006) suggested that anxiety may contribute. Indeed, the 
present study highlights the significant role that anxiety may play in MS patients lives, 
and suggests the need for clinicians to attend very carefully to patients’ anxiety. However, 
the fact that anxiety and depression were significantly correlated likely explains the 
suppression effect on the depression variable. While depression and anxiety were not 
significant in the regression model, they are relatively common phenomena among the 
MS population and should be carefully considered in the care of MS patients. Clinicians 
should also consider variables such as MS-specific worry noted by Jones and Amtmann 
(2015), as addressing health-care specific worry may have a beneficial impact on patients’ 
symptom presentation and adaptive functioning.  
The addition of the cognitive function index was significant, indicating that 
cognitive function scores contributed to the explanation of variance beyond the variance 
explained by anxiety and depression scores. The unique contribution of cognitive 
function beyond depression and anxiety is consistent with others (e.g., Matotek et al., 
2001; Smith & Arnett, 2010). The model with the cognitive function index included 
accounted for 26% of variance in estimation scores.  
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Finally, the personality scores were entered into the model and contributed to the 
explanation of variance beyond the other variables entered. The fully saturated model 
was significant and accounted for 30% of the variance in estimation scores, which is 
comparable to other studies (e.g., Akbar et al., 2011; Julian et al., 2007; & Maor et al., 
2001). However, the present study examined a unique combination of predictor variables 
that has not been previously studied. The total variance accounted for represents a 
meaningful contribution to the literature, though the explained variance could likely be 
increased with the inclusion of additional unrelated predictor variables. While the 
personality variables used in the present study were not the same as those used in 
previous studies (e.g. Akbar et al., 2011), they accounted for a similar 7% of variance in 
the criterion variable, suggesting that personality is likely related to patient symptom 
reporting in a related, yet different, manner than depression, anxiety, and cognitive 
function. Although the personality variables used in the present study were highly 
correlated with other variables (i.e. depression, anxiety), they represent unique aspects of 
personality function. Notably, the current variables denote the manner in which one 
presents her-/himself to others and the degree that one manifests psychological turmoil as 
physical symptoms. While the present personality variables accounted for unique 
variance in the estimation of memory function, they were not significant predictors in the 
final regression model. Similar to the relationship between anxiety and depression, the 
personality variables were highly correlated with each other, which may have suppressed 
their predictive contribution. The personality variables were also significantly correlated 
with other variables (i.e. depression, anxiety), which may have additionally suppressed 
the predictive effect of any of the related variables. 
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Furthermore, the small difference between R² and the adjusted R² (i.e., 0.35 vs. 
0.30, respectively) in the present study suggests that the sample was sufficiently large for 
the number of predictors used and that R² was not overly biased. If the model were over 
saturated, either via too many predictors or too few participants, one could expect a more 
inflated R² and larger discrepancy between R² and the adjusted R². Nonetheless, the 
adjusted R² value was used in the present analyses, as is common practice, because it 
accounts for the number of variables in the model and only increases when a predictor 
enhances the model beyond what would be expected by chance.  
Cognitive function emerged as the only unique predictor of MS patients’ 
estimation of memory function in the final step of the hierarchical regression analysis. 
For every 1 standard deviation unit increase in cognitive function, one can expect a .57 
standard deviation unit decrease in the estimation variable, when other variables are held 
constant. In other words, increases in cognitive function predict a decrease in the 
estimation of memory function when the depression, anxiety, and personality variables 
are fixed. However, it is important to note that the true slope of the regression line is best 
represented as a confidence interval. The estimated rate of change of estimation of 
memory function with respect to cognitive function, when the depression, anxiety, and 
personality variables are fixed, is between -.932 and -.234. Similar to others (e.g., Carone 
et al., 2005; Marrie et al. 2005), the present study may support the conclusion that 
relatively intact cognition is needed to maintain awareness of one’s cognitive function. It 
is important to remember that a decrease in estimation could mean more accurate or more 
underestimation of memory function, a differentiation that cannot be made at this time. 
The consistency of the findings in the present study is notable due to the creation of the 
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estimation score from patient reports and patient testing performance, rather than using 
informant reports. Arguably, using patient reports of function and neuropsychological test 
data to determine patient estimations is more valid than using informant reports as the 
baseline. Consistent with the present study, Goverover, Chiaravalloti et al. (2005) found 
that executive function was predictive of perceptions of function after accounting for 
affective factors. These authors also suggested that clinicians could rely on MS patients’ 
self-reports of cognitive function when cognition was intact, despite the presence of 
depression or anxiety. However, given the very limited number of variables and 
participants in their study, such a statement may be overgeneralizing. Additionally, such 
a statement risks minimizing the potential impact of psychological factors on patient 
reports of cognitive symptoms and minimizes the potential need for treatment. It may be 
that intact cognitive function is needed to maintain accurate perceptions, but the 
methodological challenges of the present study and Goverover, Chiaravalloti et al. (2005) 
do not necessarily negate the impact of other factors such as depression, anxiety, and 
personality. In fact, the present study highlights the inter-related nature of such variables 
and suggests that anxiety, mood, and personality dysfunction are relatively common 
among MS patients. Readers should consider the present findings as evidence that intact 
cognitive abilities are likely necessary for accurate estimations of memory function, 
though other variables are still likely contributory to perceptions of function. Minimally, 
clinicians should consider the presence of such factors in the MS patients they treat.  
 Although cognitive function emerged as the only unique predictor of MS patient 
estimations of memory function, the linear and curvilinear correlations between cognitive 
function and estimation of memory were notably non-significant. Although the remaining 
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predictor variables were all significantly correlated with the estimation of memory 
function in the absence of the other predictors, none were significant predictors in the 
final regression model. Such a trend was unexpected and the most likely explanation is 
model misspecification. The inclusion of the anxiety, depression, and personality 
variables, all highly related, likely suppressed variance irrelevant to the prediction of 
estimation of memory function, while potentially enhanced the effects of other predictor 
variables. Unfortunately, determining which of the predictor variables may have 
contributed suppression or inflation effects is not possible. Doing so would require 
analyses with fewer predictor variables to isolate the manner in which individual variable 
contributions change as specific predictors are included.  
Demographic Variables 
 Demographic variables were assessed to determine if estimations of memory 
function differed by sex, education level, marital status, age of MS diagnosis, or MS 
duration. Unfortunately, none of the analyses produced significant results, indicating 
males and females, individuals with more than a high school education and individuals 
with less than a high school education, married and not married individuals, those older 
than 36 years and younger than 36 years old at MS diagnosis, and individuals who had 
been diagnosed for 10 or fewer years and individuals who had been diagnosed for 10 or 
more years did not differ in their estimations of memory function. However, the effect 
size for marital status was notable. Although small, it suggests that there might be a 
relationship between marital status and the estimation of memory function within the 
population. The present study was the first to examine such relationships. Due to 
necessarily categorizing the marital status, age at diagnosis, MS duration, and education 
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variables, some degree of variability was lost. Additional research would be able to 
examine subgroups (e.g., divorced vs. never married or smaller duration intervals) with 
larger sample sizes. It is important to note that the non-significant findings regarding 
these demographic variables are distinct from the regression analyses. It is possible that 
such demographic variables are predictors of the estimation of memory function, though 
this could not be determined in the present study. 
Conclusion 
In conclusion, the present study highlights the multiple correlations that exist 
between depression, anxiety, personality, cognitive function, and the estimation of 
memory function among MS patients. Increases in anxiety, depression, somatization, and 
negative impression management were all associated with a decrease in the estimation of 
memory function. Alternatively, an increase in positive impression management was 
associated with an increase in estimation of memory function. Cognitive function was not 
significantly correlated with estimation in the absence of other predictors, though 
emerged as the only significant predictor in the regression analysis. The fact that 
cognitive function emerged as the only unique predictor may indicate that cognitive 
function is the only variable clinicians need to consider when assessing patient reported 
information, as Goverover, Chiaravalloti et al. (2005) suggested. However, as noted 
above, it is more likely that other predictive relationships were suppressed due to the high 
level of multicollinearity among anxiety, depression, negative impression management, 
and somatization. Nonetheless, the findings regarding cognitive function suggest that it 
plays an important role in self-awareness and perceptions of function. Additionally, 
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estimation of memory function did not differ by sex, education level, marital status, age 
of MS diagnosis, or MS duration. 
Limitations. The primary limitation in the present study was the construction of 
the dependent variable, which did not allow for examination of under- versus over-
reporting of memory function, as was originally intended. Unfortunately, inferences can 
only be made regarding increases or decreases in MS patients’ estimations of memory 
function. While interesting, estimations of memory performance likely have less clinical 
utility than the accuracy of MS patient predictions of function.  
Due to the relatively small sample size, the present study was not able to assess 
the association of demographic/cultural factors with the estimation of patient memory 
function. As such, the external validity of the present study is potentially limited. A larger 
sample size would have allowed for the inclusion of more variables in the regression 
analysis and greater generalizability of results.  
As mentioned earlier, nearly all predictor variables were significantly correlated 
with each other. While this fact likely reflects the manner in which such symptoms or 
characteristics are experienced in the real world, the relationships may have produced a 
suppression or inflation effect in the regression analysis. A larger sample size may have 
made the regression analysis more resistant to the impact of related predictor variables.  
The personality variables were unique to the present study. Unfortunately, this did 
not allow for overt comparison to other research. The research regarding MS cognitive 
symptom reporting, and personality is notably limited, and the present study suggests that 
personality likely plays an important role in cognitive symptom reporting. However, 
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broader statements cannot be made due to the specificity of the personality variables used 
in the present study.   
Finally, the level of psychological and cognitive impairment endorsed by 
participants was minimal, which likely resulted in less variability and weaker correlations 
and regression coefficients. Depression- and anxiety-related symptoms were generally 
endorsed at the mild level. Most personality scores were also within the average range, 
and most patients tested within the average range on cognitive testing. Notably, the 
limited variability may have prevented the observation of the curvilinear relationship that 
has been previously demonstrated between cognitive function and estimation of memory 
function.  
Clinical implications. Clinicians treating individuals with MS should assess 
cognitive function regularly, as deficits are both common and influential in MS patient 
reports of memory function. However, they should interpret subjective complaints of 
cognitive dysfunction with caution. Both the present study and extant literature suggest 
that patient reports of symptoms may vary depending on level of cognitive impairment. It 
is also likely that factors such as mood, fatigue, and implemented coping strategies may 
be related to the information patients disclose. Unfortunately, the design of the present 
study does not allow for further interpretation of the predictive role of level of cognitive 
function. Extant research suggests that greater cognitive function is associated with more 
accurate perceptions of cognitive function, though further investigation and analyses are 
needed to determine if the present study fully supports such a trend.  
Anxiety and depression are notably common among MS patients, a fact clinicians 
should consider carefully. While the present study does not support the predictive role of 
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such variables in MS patient estimations of memory function, it does support their 
relatively common presence. Although anxiety and depression were both reported at a 
mild level, on average, it is important to consider the episodic and progressive nature of 
MS and the potential for worsening function at times, and related increases in anxiety and 
depression. As such, dismissing the potential role of anxiety and depression would be a 
disservice to patients. MS patients with relatively intact cognitive capacities may be 
correctly reporting their memory function, while also suffering from psychological 
disturbances. As such, clinicians should regularly assess for symptoms of mood 
disturbances and anxiety with MS patients. Doing so could be done in a cost effective and 
rapid manner with self-administered screening assessments, and would allow for the 
proper comprehensive treatment of MS patients. In fact, previous studies (e.g. Kinsinger 
et al., 2010; Julian et al., 2007) suggested that the successful treatment of depression 
could lead to reduced cognitive complaints among MS patients. Personality disturbance 
should also be considered by clinicians, as it is also likely common among MS patients 
(Rintell, 2012) and likely related to MS patient-reported cognitive symptoms. However, it 
would be more difficult to assess personality patterns in a rapid manner, and may need to 
be assessed by clinicians in more extreme cases of misreporting. Additionally, more 
research is needed to establish the prevalence and types of personality alterations that 
occur in MS patients.  
Finally, clinicians should facilitate protective factors such as self-efficacy, or 
patients’ beliefs that they can manage challenging situations, when possible. Recent 
research (Schmitt et al., 2014) found that self-efficacy was a significant predictor of 
increased physical functioning, subjective cognitive functioning, and social functioning 
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in MS patients. Increasing self-efficacy could be accomplished with the implementation 
of self-management interventions (Rae-Grant et al., 2011), which could include patients’ 
increasing their knowledge of MS, sharing in medical decision making; adopting a 
lifestyle that addresses risk factors; focusing on prevention and early intervention; 
actively monitoring symptoms; and managing the physical, emotional, social, and 
occupational consequences of the condition. Such interventions may increase self-
efficacy and help produce functional changes in patients. It is important for treating 
providers to promote patient function as much as possible, and facilitating protective 
factors such as self-efficacy is one way to do so.  
The treatment of MS thus should be approached in a multifactorial fashion, as MS 
is truly a multifaceted disease. Managing cognitive decline, pain, and physical 
dysfunction represent the more tangible aspects of MS. However, equally deserving of 
treatment, though not necessarily as observable, are aspects of chronic illness such as 
excessive worry, depression, fatigue, social isolation, occupational impairment, and 
alterations of personality, which are likely related to the expression of physical symptoms. 
MS is a complicated chronic illness, and the variables examined in the present study 
likely represent a small fraction of those that are actually related to cognitive symptom 
reporting. Identifying and treating the wide range of symptoms associated with MS and 
fostering protective factors may impact patient self-reports of cognitive symptoms and, 
perhaps more significantly, could impact quality of life for patients suffering from the 
chronic and debilitating effects of a devastating disease.  
Research implications. Patient perceptions, estimations, and subsequent reports 
of symptoms remain one of the most common ways providers receive information. The 
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need to understand the factors related to patient symptom reporting is significant, as 
identifying and treating such factors may have profound effects on lives of patients with 
MS.  
Future research should analyze a lager sample and a dependent variable that can 
be separated into underestimating, accurate, and overestimating performance, and then 
analyze the associations with psychological variables. Doing so would be possible with a 
procedure such as discriminant function analysis or multinomial logistic regression, and 
could allow for more clinically applicable findings. It is likely that MS patients who over 
report vs. under report cognitive difficulty are characteristically different, and 
understanding such differences remains necessary for the appropriate treatment of MS 
patients. Additionally, structural equation modeling could be utilized to more accurately 
map the complex relationships between predictor and criterion variables.   
Future study should also increase sample size, sample variability, and continue to 
investigate the relationship between psychological variables and cognitive symptom 
reporting. Related predictor variables, such as those in the present study, may be 
combined using statistical procedures such as Principle Component Analysis to create 
non-related predictors. An increased sample size would allow for the inclusion of 
demographic and other psychosocial variables in the analyses, as was originally intended 
with the present study. For example, recent research (i.e., Beier et al., 2015) suggests that 
fatigue is predictive of cognitive symptom reporting. Research should continue to 
identify important variables that are related to cognitive symptom reporting, as doing so 
would allow treating providers to target interventions with the greatest chance of clinical 
impact. In this regard, researchers should also continue to investigate protective factors, 
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such as self-efficacy. Identifying and facilitating protective factors may affect the 
accuracy of patient self-report, but could also lead to improved patient functioning.   
When possible, future study should account for the varied types of MS. There 
were very few MS types specified in patient charts for the present study. Although this 
lack of specificity does not alter the current analyses, there can be no differentiation 
between types of MS, which differ in multiple ways, as noted previously. It is possible 
that patients with different types of MS experience varying degrees of depression, anxiety, 
cognitive impairment, and personality disturbance. Finally, although the duration of MS 
was not used in the present analysis, data collection revealed an interesting trend that 
should be integrated into future research: There was a notably varied report of when 
patients were diagnosed with MS and when they first experienced symptoms. Some 
patients experienced their first symptoms and almost immediately sought consultation 
with a physician, resulting in their MS diagnosis. However, others noted experiencing 
symptoms of MS and not receiving a diagnosis for up to 17 years later. Such a 
discrepancy is worthy of investigation, as multiple factors could have been contributory. 
It is possible that individuals had different types of MS, resulting in varied symptom 
presentation and severity. It is also possible that individuals had varying levels of 
knowledge of MS symptoms, access to care, social support, personality characteristics, or 
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